Tesamorelin
Also known as: Egrifta
Tesamorelin (Egrifta / Egrifta SV) is a stabilized analog of human GHRH(1-44) with a trans-3-hexenoic acid moiety at the N-terminus that protects against protease degradation. FDA-approved in November 2010 for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, it is the only FDA-approved GHRH analog for this indication. Off-label use for general body composition and visceral fat reduction in non-HIV populations is common but outside the approved label.
Pricing for Tesamorelin
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
Average price
$8.91/mg
range $3.40–$76.50/mg
Sellers
85
from $0.00
45-day trend
-14.4%
vs 45-day avg $/mg
79 of 85 sellers have a current price· 45 stale listings hidden (not seen in 7 days)
Top Merit pick
🇺🇸 Glacier Aminos99✓ verified at source · 23h ago
$3.40/mg -61.8% vs avg$67.99
20mg
- 🇺🇸 Peptide Partners99
via Disclosed Labs · 23h ago
$4.49/mg -49.6% vs avg$898
200mg
99.8% purity 28 COAs - 🇺🇸 Moglabs96
via Disclosed Labs · 23h ago
$10.00/mg +12.3% vs avg$50.00
5mg
99.2% purity 2 COAs - 🇺🇸 BioLongevity Labs96
✓ verified at source · 22h ago
$15.00/mg +68.4% vs avg$150
10mg
- 🇺🇸 Reta One Labs95
✓ verified at source · 22h ago
$3.90/mg -56.2% vs avg$39.00
10mg
- 🇺🇸 Profound Aminos95
via Disclosed Labs · 23h ago
$5.45/mg -38.8% vs avg$109
20mg
99.9% purity 4 COAs - 🇺🇸 Prime Peptides95
via Disclosed Labs · 23h ago
$6.00/mg -32.6% vs avg$60.00
10mg
- 🇺🇸 Orbitrex Peptides95
via Disclosed Labs · 23h ago
$7.00/mg -21.4% vs avg$69.99
10mg
99.1% purity 7 COAs - 🇺🇸 Licensed Peptides95
✓ verified at source · 22h ago
$76.50/mg +758.7% vs avg$765
10mg
- 🇺🇸 Forge Performance Co.94
✓ verified at source · 22h ago
$6.00/mg -32.6% vs avg$60.00
10mg
- 🇺🇸 Riptide Wellness92
via Disclosed Labs · 23h ago
$5.85/mg -34.3% vs avg$117
20mg
99.7% purity 2 COAs - 🇺🇸 Hydro Research Peptides91
✓ verified at source · 22h ago
$5.50/mg -38.3% vs avg$55.00
10mg
- 🇺🇸 Peptide Plugs89
✓ verified at source · 23h ago
$7.00/mg -21.4% vs avg$70.00
10mg
- 🇺🇸 Peptidology89
✓ verified at source · 23h ago
$7.50/mg -15.8% vs avg$75.00
10mg
- 🇺🇸 Sunrise Bioresearch88
via Disclosed Labs · 23h ago
$4.85/mg -45.5% vs avg$97.04
20mg
99.1% purity 9 COAs - 🇺🇸 Verified Peptides86
via Disclosed Labs · 23h ago
$5.95/mg -33.2% vs avg$119
20mg
- 🇺🇸 EZ Peptides85
✓ verified at source · 23h ago
$6.80/mg -23.7% vs avg$68.00
10mg
99.8% purity 6 COAs - 🇺🇸 Simple Peptide85
✓ verified at source · 22h ago
$7.50/mg -15.8% vs avg$75.00
10mg
- 🇺🇸 Ascension Peptides84
via Disclosed Labs · 23h ago
$10.00/mg +12.3% vs avg$50.00
5mg
no purity - Peptide Supply Co.83
via Disclosed Labs · 23h ago
$3.50/mg -60.7% vs avg$700
200mg
- 🇨🇳 Reta Peptide83
✓ verified at source · 23h ago
$18.00/mg +102.1% vs avg$180
10mg
99.8% purity 8 COAs - 🇺🇸 Blank Peptides81
✓ verified at source · 23h ago
$9.50/mg +6.6% vs avg$95.00
10mg
99.4% purity 4 COAs - 🇺🇸 OROS Research79
via Disclosed Labs · 23h ago
$9.00/mg +1% vs avg$89.99
10mg
99.0% purity 6 COAs - 🇺🇸 Texpeptide65
✓ verified at source · 22h ago
$6.50/mg -27% vs avg$65.00
10mg
no purity - 🇺🇸 Certified Peptides62
✓ verified at source · 23h ago
$8.90/mg -0.1% vs avg$89.00
10mg
no purity 1 COA - 🇭🇰 zztai Peptide Ltd43
✓ verified at source · 23h ago
$18.10/mg +103.2% vs avg$181
10mg
no purity - 🇺🇸 Alpha PeptidesUnscored
via Disclosed Labs · 23h ago
$4.32/mg -51.5% vs avg$43.22
10mg
no purity - 🇺🇸 NG PeptideUnscored
via Disclosed Labs · 23h ago
$4.50/mg -49.5% vs avg$90.00
20mg
no purity - optimasupply.isUnscored
via Disclosed Labs · 23h ago
$5.50/mg -38.3% vs avg$55.00
10mg
no purity - peptidetech.isUnscored
via Disclosed Labs · 23h ago
$7.00/mg -21.4% vs avg$69.99
10mg
no purity - volterasciences.comUnscored
via Disclosed Labs · 23h ago
$7.00/mg -21.4% vs avg$69.99
10mg
no purity - 🇺🇸 Kimera ChemsUnscored
via Disclosed Labs · 23h ago
$8.20/mg -8% vs avg$81.99
10mg
no purity - realpeptides.coUnscored
via Disclosed Labs · 23h ago
$9.50/mg +6.6% vs avg$95.00
10mg
no purity - 🇺🇸 Arcane PeptidesUnscored
via Disclosed Labs · 23h ago
$10.00/mg +12.3% vs avg$50.00
5mg
no purity
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
COAs for Tesamorelin
259 third-party tests across 34 vendors. Each card links to the full report.
For
Tesamorelin
by NG Peptide· batch TSM-13
For
Tesamorelin
by Optima Supply· batch OS-2026-1763
For
Tesamorelin
by Hydro Research Peptides· batch HR-2026-4509
For
Tesamorelin
by NG Peptide· batch tsm20-04
For
Tesamorelin
by Profound Aminos· batch Black Cap
For
Tesamorelin
by Peptide Partners· batch TES202607
For
Tesamorelin
by Voltera Sciences· batch TSM10-06022026
For
Tesamorelin
by Peptide Plugs· batch 136-02-SM-WT
For
Tesamorelin
by Blank Peptides· batch B-3699671-P
For
Tesamorelin
by Voltera Sciences· batch TSM10.05.28.26
For
Tesamorelin
by Verified Peptides· batch TM07261020J
For
Tesa
by Ion Peptide· batch TSM10-06022026
For
Tesamorelin
by Peptide Partners· batch SPL-3947
For
Tesamorelin
by OROS Research· batch OR-LPTES5-526-B6
For
Tesamorelin
by Ion Peptide· batch TSM20-05142026
For
Tesamorelin
by Glacier Aminos· batch TES10GA-07
For
Tesamorelin
by Crush Research· batch CR-TSM20-0307-1
For
Tesamorelin
by Skye Peptides· batch TESA26-10-002
For
Tesamorelin
by Skye Peptides· batch TESA26-20-004
For
Tesamorelin/Ipamorelin
by Licensed Peptides· batch Green Cap
For
Tesamorelin
by NG Peptide· batch TSM20-3
For
Tesamorelin
by Forge Performance Co.· batch Clear Blue Cap
For
Tesamorelin
by Ion Peptide· batch TSM10-05042026
For
Tesamorelin
by Ion Peptide· batch TSMH10-0504206
23 citations indexed for Tesamorelin
Study · 2026
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol
Background The Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH) study is a randomised controlled trial with the overall goal of examining the combined effect of exercise and the growth hormone-releasing hormone analogue tesamorelin on physical function.
case-report · 2026
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists
Background Excess visceral abdominal fat (EVAF) is a prevalent metabolic complication among people living with HIV-1 (PLWH), occurring even in individuals with normal or mildly elevated body mass index (BMI).
animal · 2026
Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model
The introduction of combination antiretroviral therapy (cART) has significantly reduced AIDS-related morbidity and mortality. However, the prevalence of age-associated comorbidities, particularly cardiovascular diseases (CVD), has increased, becoming a leading cause of mortality in people living with HIV.
meta-analysis · 2026
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials
Background HIV-associated lipodystrophy leads to visceral fat accumulation, metabolic complications, body image concerns, medication non-adherence, and increased cardiovascular risks.
review · 2026
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Performance-enhancing drugs (PEDs) marketed as "research compounds" include unregulated peptides intended to modulate the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.
Study · 2026